[1]关丫丫,钟根深,王伟,等.三磷腺苷合酶抑制因子1对2型糖尿病的诊断效能[J].新乡医学院学报,2023,40(5):448-452.[doi:10.7683/xxyxyxb.2023.05.009]
　GUAN Yaya,ZHONG Genshen,WANG Wei,et al.Diagnostic efficacy of adenosine triphosphate synthase inhibitory factor 1 in type 2 diabetes mellitus[J].Journal of Xinxiang Medical University,2023,40(5):448-452.[doi:10.7683/xxyxyxb.2023.05.009]
点击复制

三磷腺苷合酶抑制因子1对2型糖尿病的诊断效能
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年5
页码:
448-452
栏目:
临床研究
出版日期:
2023-05-05

文章信息/Info

Title:
Diagnostic efficacy of adenosine triphosphate synthase inhibitory factor 1 in type 2 diabetes mellitus
文章编号:
20230509
作者:
关丫丫1; 钟根深2; 3; 王伟1; 路申1; 杨秀珍1; 叶建平4
（1.新乡医学院第三附属医院检验科/新乡医学院第三临床学院，河南　新乡　453003；2.新乡医学院医学检验学院，河南　新乡　453003；3.河南省分子诊断与医学检验技术协同创新中心，河南　新乡　453003；4.郑州大学附属郑州中心医院代谢研究中心，河南　郑州　450007）
Author(s):
GUAN Yaya1; ZHONG Genshen2; 3; WANG Wei1; LU Shen1; YANG Xiuzhen1; YE Jianping4
关键词:
三磷腺苷合酶抑制因子1; 2型糖尿病; 诊断效能
Keywords:
（1.Department of Clinical Laboratory; the Third Affiliated Hospital of Xinxiang Medical University/the Third Clinical College of Xinxiang Medical University; Xinxiang 453003; 2.College of Laboratory Medicine; Xinxiang Medical University; Xinxiang 453003; 3.Collaborative Innovation Center of Molecular Diagnosis and Medical Laboratory Technology of Henan Province; Xinxiang 453003; 4.Metabolic Research Center; Zhengzhou Central Hospital Affiliated to Zhengzhou University; Zhengzhou 450007)
分类号:
R587.1
DOI:
10.7683/xxyxyxb.2023.05.009
文献标志码:
A
摘要:
目的　探讨血清中三磷腺苷合酶抑制因子1 (ATPIF1）对2型糖尿病（T2DM）的诊断效能。方法　选择2021年5月至2021年9月新乡医学院第三附属医院内分泌科收治的80例T2DM患者为研究对象（T2DM组）；另选择同期80例体检健康者为健康对照组。采集2组患者空腹外周静脉血，应用己糖激酶法检测血清血糖（GLU）水平，氧化酶法检测血清总胆固醇（TC）、三酰甘油（TG）水平，直接法检测血清高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）水平，酶联免疫吸附法检测血清中胰岛素（INS）、C-肽和ATPIF1水平，离子交换高效液相色谱法检测糖化血红蛋白（HbA1c）水平，实时荧光定量聚合酶链式反应法检测外周血单核细胞中ATPIF1 mRNA相对表达量。采用受试者操作特征（ROC) 曲线下面积（AUC）评估血清ATPIF1水平、外周血单核细胞ATPIF1 mRNA相对表达量诊断T2DM的效能。结果　T2DM组患者的GLU、HbA1c、INS和C-肽水平显著高于健康对照组，血清ATPIF1水平和外周血单核细胞ATPIF1 mRNA相对表达量显著低于健康对照组（P<0.05）；2组受试者的TC、TG、HDL-C、LDL-C水平比较差异无统计学意义（P>0.05）。血清ATPIF1预测T2DM的AUC为0.916（95%置信区间：0.873~0.960，P<0.05）；当ATPIF1以 1.37 μg·L-1为截断点时，Youden指数为0.738，敏感度为93.8%，特异度为80.0%。外周血单核细胞中ATPIF1 mRNA相对表达量预测T2DM的AUC为0.965（95%置信区间：0.943~0.988，P<0.05）；当ATPIF1 mRNA相对表达量以0.95为截断点时，Youden指数为0.838，敏感度为83.8%，特异度为100.0%。血清ATPIF1水平和外周血单核细胞ATPIF1 mRNA相对表达量预测T2DM的Youden指数显著低于GLU和HbA1c，显著高于INS和C-肽（P<0.001）。
结论　血清ATPIF1水平和外周血单核细胞中ATPIF1 mRNA表达水平降低会增加T2DM的患病风险，可作为诊断T2DM的生物标志物。
Abstract:
Objective　To investigate the diagnostic efficacy of adenosine triphosphate synthase inhibitory factor 1 (ATPIF1) in type 2 diabetes mellitus (T2DM).
Methods　A total of 80 patients with T2DM admitted to the Department of Endocrinology of the Third Affiliated Hospital of Xinxiang Medical University from May 2021 to September 2021 were selected as the research subjects (T2DM group).In addition,80 cases of healthy people with physical examination during the same period were selected as the healthy control group.Fasting peripheral venous blood were collected from subjects in the two groups.The serum glucose (GLU) was detected by hexokinase method,the total cholesterol (TC) and triacylglycerol (TG) levels in serum were detected by oxidase method;the high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C) levels in serum were detected by direct method;the insulin (INS),C-peptide and ATPIF1 levels in serum were detected by enzyme-linked immunosorbent;the glycosylated hemoglobin(HbA1c) level was detected by ion exchange high performance liquid chromatography;the expression of ATPIF1 mRNA in peripheral blood mononuclear cells was detected by real-time polymerase chain reaction.The efficacy of serum ATPIF1 level and the relative expression of ATPIF1 mRNA in peripheral blood mononuclear cells in the diagnosis of T2DM was evaluated by area under curve (AUC) of receiver operating characteristic (ROC) curve.
Results　The levels of GLU,HbA1c,INS and C-peptide of patients in the T2DM group were significantly higher than those in the healthy control group,and the serum ATPIF1 level and the relative expression of ATPIF1 mRNA in peripheral blood mononuclear cells were significantly lower than those in the healthy control group (P<0.05);there was no significant difference in TC,TG,HDL-C and LDL-C levels of subjects between the two groups (P>0.05).The AUC of serum ATPIF1 predicting T2DM was 0.916,when ATPIF1 was at 1.37 μg·L-1 as the cut-off point,the Youden index was 0.738,the sensitivity was 93.8%,and the specificity was 80.0%;the AUC of the relative expression of ATPIF1 mRNA in peripheral blood mononuclear cells in predicting T2DM was 0.965,when the relative expression of ATPIF1 mRNA was cut off at 0.95,the Youden index was 0.838,the sensitivity was 83.8%,and the specificity was 100.0%.The Youden index of serum ATPIF1 level and the relative expression of ATPIF1 mRNA in peripheral blood mononuclear cell in predicting T2DM was significantly lower than that of GLU and HbA1c,and higher than that of INS and C-peptide(P<0.001).
Conclusion　Decreasing serum ATPIF1 levels and ATPIF1 mRNA expression in peripheral blood mononuclear cells can increase the risk of T2DM,and which can be used as the biomarkers for diagnosing T2DM.

参考文献/References:

［1］　FASELIS C,KATSIMARDOU A,IMPRIALOS K,et al.Microvascular complications of type 2 diabetes mellitus［J］.Curr Vasc Pharmacol,2020,18(2):117-124.
［2］　ZHENG Y,LEY S H,HU F B.Global aetiology and epidemiology of type 2 diabetes mellitus and its complications［J］.Nat Rev Endocrinol,2018,14(2):88-98
［3］　MONTGOMERY M K,TURNER N.Mitochondrial dysfunction and insulin resistance:an update［J］.Endocr Connect,2015,4(1):R1-R15.
［4］　ROVIRA-LLOPIS S,BAULS C,DIAZ-MORALES N,et al.Mitochondrial dynamics in type 2 diabetes:pathophysiological implications［J］.Redox Biol,2017,11:637-645.
［5］　ANTOUN G,MCMURRAY F,THRUSH A B,et al.Impaired mitochondrial oxidative phosphorylation and supercomplex assembly in rectus abdominis muscle of diabetic obese individuals［J］.Diabetologia,2015,58(12):2861-2866.
［6］　SIVITZ W I,YOREK M A.Mitochondrial dysfunction in diabetes:from molecular mechanisms to functional significance and therapeutic opportunities［J］.Antioxid Redox Signal,2010,12(4):537-577.
［7］　PETERSEN K F,BEFROY D,DUFOUR S,et al.Mitochondrial dysfunction in the elderly:possible role in insulin resistance［J］.Science,2003,300(5622):1140-1142.
［8］　PETERSEN K F,DUFOUR S,BEFROY D,et al.Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes［J］.N Engl J Med,2004,350(7):664-671.
［9］　KELLEY D E,HE J,MENSHIKOVA E V,et al.Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes［J］.Diabetes,2002,51(10):2944-2950.
［10］　MAECHLER P,WOLLHEIM C B.Mitochondrial function in normal and diabetic beta-cells［J］.Nature,2001,414(6865):807-812.
［11］　GORE E,DUPARC T,GENOUX A,et al.The multifaceted ATPase inhibitory factor 1 (IF1) in energy metabolism reprogramming and mitochondrial dysfunction:a new player in age-associated disorders［J］.Antioxid Redox Signal,2022,37(4/6):370-393.
［12］　GENOUX A,PONS V,RADOJKOVIC C,et al.Mitochondrial inhibitory factor 1 (IF1) is present in human serum and is positively correlated with HDL-cholesterol［J］.PLoS One,2011,6(9):e23949.
［13］　GENOUX A,RUIDAVETS J B,FERRIRES J,et al.Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease:the GENES study［J］.J Lipid Res,2013,54(9):2550-2558.
［14］　GENOUX A,LICHTENSTEIN L,FERRIRES J,et al.Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease:the GENES study［J］.BMC Med,2016,14(1):125.
［15］　关丫丫,梁银明,王辉,等.三磷腺苷合酶抑制因子1基因敲除对小鼠成纤维细胞中三磷腺苷水平及脂肪细胞分化的影响［J］.新乡医学院学报,2018,35(8):658-661.
GUAN Y Y,LIANG Y M,WANG H,et al.Effect of adenosine triphosphate synthase inhibitory factor 1 gene knockout on ATP level and differentiation of adipocytes in fibroblasts of mice［J］.J Xinxiang Med Univ,2018,35(8):658-661.
［16］　中华医学会糖尿病学分会.中国2型糖尿病防治指南（2020年版）［J］. 中华糖尿病杂志,2021,13(4):315-409.
CHINESE DIABETES SOCIETY.Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)［J］.Chin J Diabetes Mellitus,2021,13(4):315-409.
［17］　YE J.Mechanism of insulin resistance in obesity:a role of ATP［J］.Front Med,2021,15(3):372-382.
［18］　ZHANG Y,YE J.Mitochondrial inhibitor as a new class of insulin sensitizer［J］.Acta Pharm Sin B,2012,2(4):341-349.
［19］　ESPARZA-MOLT P B,CUEZVA J M.The role of mitochondrial H+-ATP synthase in cancer［J］.Front Oncol,2018,8:53.
［20］　KWAK S Y,CHUNG I,KANG J,et al.Sex specific effect of ATPase inhibitory factor 1 on body weight:studies in high fat diet induced obese mice and genetic association studies in humans［J］.Metabolism,2020,105:154171.

相似文献/References:

[1]翁孝刚.2型糖尿病与胰岛B一细胞功能[J].新乡医学院学报,2002,19(03):231.
[2]汪裕荣.血脂康联合小剂量阿司匹林治疗2型糖尿病并高脂血症的长期疗效观察[J].新乡医学院学报,2002,19(05):391.
[3]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[4]何伟玺.冠心病与2型糖尿病患者心率变异性对比分析[J].新乡医学院学报,2003,20(04):282.
[5]李万森,毛向莹,邱培勇.2型糖尿病合并脑梗死50例临床分析[J].新乡医学院学报,2003,20(05):353.
[6]殷国田,崔瑞花.益津降糖胶囊治疗2型糖尿病42例[J].新乡医学院学报,2003,20(05):372.
[7]新乡市第二人民医院内分泌科 河南新乡.依那普利对2型糖尿病合并高血压患者血压及胰岛素敏感性指数的影响[J].新乡医学院学报,2005,22(03):267.
[8]蒋铁桥,张群,杨刚毅,等.短期胰岛素泵强化治疗对初诊2型糖尿病患者β细胞功能的影响[J].新乡医学院学报,2010,27(04):000.
[9]王润之,黄艳群.LPIN1基因的研究进展[J].新乡医学院学报,2010,27(04):413.
[10]姥勇,屈阳,朱旅云,等.脂联素与2型糖尿病血管病变的关系[J].新乡医学院学报,2011,28(01):089.

更新日期/Last Update: 2023-05-22